Clinical Trial Update: Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial of NKTR-181 in opioid-naive individuals with low back pain/chronic pain completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Pain

Drugs mentioned

• NKTR-181

Snippet

Sponsor: Nektar Therapeutics | Conditions: Low Back Pain, Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-09-16